Streetbeat News

Stock Prices

HBAN

Jefferies analyst Ken Usdin upgrades Huntington Bancshares (NASDAQ:HBAN) from Hold to Buy and raises the price target from $14 to $16.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 6:55 pm

SQM

Jefferies analyst Alejandro Demichelis upgraded Sociedad Quimica Y Minera (SQM) from Hold to Buy and increased the price target from $52 to $62.8, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 6:54 pm

AUUD

LGVN

PERI

PLOW

WTO

U.S. stocks traded higher with the Nasdaq Composite gaining 0.1%. Consumer discretionary shares jumped by 0.9%, while health care shares fell by 0.3%. Perion Network Ltd. (NASDAQ:PERI) cut its FY24 revenue guidance significantly. Auddia Inc. (NASDAQ:AUUD) surged 199% after being awarded a U.S. Patent for its AI technology in the faidr app. UTime Limited (NASDAQ:WTO) and Longeveron Inc. (NASDAQ:LGVN) also saw significant gains. Douglas Dynamics, Inc. (NYSE:PLOW) fell after a downgrade by Baird. Gold and silver prices increased.

Portfolio Pulse from Avi Kapoor

April 08, 2024 | 6:51 pm

TONUSD

Toncoin (CRYPTO: TON) surged 16.5% to a new all-time high of $6.25 following the announcement of a new palm scanning identity verification system by the TON network. This growth is attributed to several factors including a new financial reward system for Telegram channel owners announced by Telegram founder Pavel Durov and a preliminary valuation of Telegram at $30 billion. The TON network, revived in 2022 as The Open Network, has introduced this palm scanning initiative in partnership with AI company HumanCode, offering a privacy-focused method of identity verification.

Portfolio Pulse from Murtuza Merchant

April 08, 2024 | 6:49 pm

ABEV

GILD

SBUX

Starbucks, Gilead Sciences, and Ambev have hit their 52-week lows, presenting potential buy-the-dip opportunities. Starbucks trades around $86.83 with a potential upside of 17.23%, Gilead at $69.32 with a 20.16% upside, and Ambev at $2.40 with a 32.51% upside, according to recent analyst ratings.

Portfolio Pulse from Surbhi Jain

April 08, 2024 | 6:47 pm

ELF

Recent options trading activity for e.l.f. Beauty (NYSE:ELF) shows a mixed sentiment among investors, with a slight bearish lean. Analysis of 11 trades reveals 45% bullish and 54% bearish positions. The focus is on a price range of $115.0 to $185.0. The largest trades include both bullish and bearish expectations, with significant activity in calls and puts. e.l.f. Beauty, a US-based cosmetics company, is currently trading at $162.0, with a neutral RSI and an anticipated earnings release in 44 days. Analysts have given mixed reviews, with an average target price of $221.25.

Portfolio Pulse from Benzinga Insights

April 08, 2024 | 6:45 pm

MDIA

SOHU

TSQ

Four stocks in the communication services sector, Townsquare Media, Inc. (TSQ), Sohu.com Limited (SOHU), So-Young International Inc. (SY), and MediaCo Holding Inc. (MDIA), are considered overbought according to their RSI values, indicating potential short-term performance issues. Recent company developments and stock movements are highlighted, with TSQ and SOHU posting positive financial results, SY showing strong earnings, and MDIA experiencing a significant stake acquisition by Standard General L.P.

Portfolio Pulse from Avi Kapoor

April 08, 2024 | 6:40 pm

LOMA

Loma Negra's stock price increased following an upgrade by B of A Securities from Underperform to Neutral, with a raised price target from $7.1 to $8.1.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 6:39 pm

ALNY

RHHBY

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) presented mixed results from the KARDIA-2 Phase 2 study of zilebesiran for hypertension, showing efficacy with indapamide and amlodipine but not with olmesartan. Despite this, analysts from JMP Securities and William Blair express confidence in the drug's potential, recommending ALNY shares with an Overweight rating and a price target of $217. Alnylam, in partnership with Roche Holdings AG (OTC:RHHBY), is advancing zilebesiran into further trials. ALNY shares rose 2.46% to $157.34.

Portfolio Pulse from Vandana Singh

April 08, 2024 | 6:37 pm

LGVN

Longeveron Inc (NASDAQ:LGVN) shares surged over 50% after announcing a share offering and a letter from CEO Wa’el Hashad marking his first year. The letter highlighted progress in developing Lomecel-B™ for diseases like HLHS and Alzheimer’s, success in Phase 1 trials for HLHS, ongoing Phase 2 trials, and strategic collaborations for funding. The company is seeking additional capital through a reverse stock split and registration statement to meet 2024 operational goals.

Portfolio Pulse from Henry Khederian

April 08, 2024 | 6:28 pm